India to Saudi Arabia: Methotrexate Export Trade Route

The India to Saudi Arabia Methotrexate corridor is one of India's established pharmaceutical export routes, with 123 shipments documented worth a combined $1.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's methotrexate manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $14.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #9 among India's top methotrexate export destinations globally.

On the import side, key buyers of Indian methotrexate in Saudi Arabia include TO SAUDI AWAL BANK, SUDAIR PHARMA COMPANY, SUDAIR PHARMA COMPANY and 31 others. TO SAUDI AWAL BANK is the single largest importer with 3 shipments valued at $599.3K USD.

India's methotrexate exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , VENUS REMEDIES LIMITED — together account for 88% of total trade value on this route. The average shipment value of $14.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as methotrexate spc 2.5 tablets (methotrexa and methotrexate spc 2.5 tablets (methotrexate 2.5mg) (inv.qty.47880 pack 10x10s=4788000 nos), suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO SAUDI AWAL BANK is the largest importer with 3 shipments worth $599.3K USD — representing 33% of all methotrexate imports from India on this route. A total of 34 buyers are active on this corridor.